As shown in Table 3 and Figure 5, TNF, IFNG, PTGS2, NOS2, VCAM-1, and interleukin-2 (IL-2) got the highest MCC scores and were thus regarded as the core targets of TWH for BD treatment. This evidence concerns the gene NOS2 and Behcet disease.